- Published on
Emergency and Acute Medicine – Tinea Infections (Cutaneous)
Cutaneous tinea infections are superficial fungal infections involving the hair, skin, or nails, typically confined to the stratum corneum. They are among the most common diseases worldwide and require keratin for growth, which explains why mucosal surfaces are not affected. These infections are named according to their anatomical location. The causative organisms are dermatophytes, primarily species of Microsporum, Trichophyton, and Epidermophyton. In contrast, tinea versicolor is caused by Malassezia furfur, a yeast, and is not a true dermatophyte infection. Transmission may occur via direct contact with infected individuals, animals, or contaminated soil, and skin trauma or maceration facilitates fungal entry. In children, spread can occur through shared items such as toys or brushes, while nail infections are uncommon unless associated with conditions like immunosuppression or Down syndrome.
Clinical presentation varies depending on the site of infection but is generally characterized by itching as the main symptom. Tinea capitis primarily affects children and presents with scalp involvement, including alopecia, scaling, and characteristic “black dots” from broken hairs. Inflammatory forms such as kerion may appear as boggy, purulent masses with associated lymphadenopathy. Tinea corporis, or ringworm, presents as annular lesions with raised, well-demarcated borders and central clearing, commonly affecting the trunk and extremities. Tinea cruris involves the groin, thighs, and buttocks, producing erythematous, scaly patches that typically spare the scrotum and penis, helping differentiate it from candidiasis. Tinea pedis, the most common form in adults, manifests as scaling, maceration, and fissuring between the toes, often associated with moisture and poor foot hygiene. Tinea unguium (onychomycosis) causes thickened, discolored nails with subungual debris and nail separation. Tinea versicolor presents with hypo- or hyperpigmented macules on the upper trunk, arms, and neck, especially in warm climates.
Diagnosis is primarily clinical, based on history and physical examination. If uncertainty exists, confirmation can be achieved through microscopy using potassium hydroxide (KOH) preparation, which demonstrates fungal elements such as septate hyphae in dermatophyte infections or the characteristic “spaghetti and meatballs” pattern in Malassezia. Fungal cultures are generally not necessary due to slow growth. Wood lamp examination has limited utility, as most dermatophytes do not fluoresce, although Microsporum species may appear green and Malassezia yellow-green.
Treatment depends on the site and severity of infection. Most superficial infections such as tinea corporis, cruris, and pedis respond well to topical antifungals, including terbinafine or imidazoles like clotrimazole and miconazole. Keeping the affected area dry and maintaining hygiene are important adjuncts. In contrast, infections involving hair or nails, such as tinea capitis and tinea unguium, require systemic therapy because topical agents do not adequately penetrate these structures. Oral terbinafine is commonly used and is considered first-line for tinea capitis, while longer treatment durations are required for nail infections. Selenium sulfide or ketoconazole shampoos may reduce transmission in scalp infections. Tinea versicolor is typically treated with topical agents such as selenium sulfide shampoo or topical azoles, with oral therapy reserved for extensive or refractory cases.
Most patients improve within 1–2 weeks of treatment, although hair and nail infections require prolonged therapy lasting several months. Patients can usually be managed as outpatients, with hospital admission reserved for rare cases of invasive infection in immunocompromised individuals or complicated kerion with secondary bacterial infection. Follow-up is important for patients on oral antifungal therapy to monitor for adverse effects, particularly hepatotoxicity.
Key clinical pearls include recognizing tinea capitis as the most common dermatophyte infection in children and understanding that itching is the predominant symptom across most forms. Tinea pedis can predispose to cellulitis, and recurrence of infections, particularly in the feet and groin, is common. Preventive measures such as proper hygiene and avoiding sharing personal items are essential to reduce reinfection and transmission.
- Published on
Infectious Disease And Microbiology – Epiglottitis
Epiglottitis is a rapidly progressive and potentially life-threatening infection of the epiglottis and surrounding supraglottic structures. It is considered a medical emergency because it can lead to sudden airway obstruction and respiratory failure if not promptly recognized and treated.
The incidence of epiglottitis has declined significantly in countries with widespread vaccination against Haemophilus influenzae type b (Hib). However, it still occurs, particularly in adults, with an incidence of approximately 0.9–3.1 cases per 100,000 individuals. The average age of affected adults is around 45 years. Risk factors include young age (especially under 4 years), lack of vaccination, immunodeficiency, post-splenectomy status, and nonimmune adults. In the post-vaccination era, the average age of affected children has increased.
Prevention primarily involves immunization against H. influenzae type b. In cases where a patient has confirmed Hib epiglottitis and there are unvaccinated children under 4 years in the household, rifampin prophylaxis is recommended for all household members and the patient to eliminate bacterial carriage.
The most common causative organism in children remains H. influenzae type b, accounting for over 90% of pediatric cases. In adults, a wider range of pathogens may be involved, including Streptococcus pneumoniae, group A streptococci, Staphylococcus aureus, and Haemophilus parainfluenzae. In immunocompromised patients, fungal organisms such as Candida and Aspergillus may be implicated. Viral infections, including varicella-zoster virus, herpes simplex virus, HIV, and infectious mononucleosis, may also be associated with epiglottitis.
Clinically, the onset is usually acute. Children typically present within 24 hours with fever, difficulty speaking (dysphonia), difficulty swallowing (dysphagia), irritability, and drooling. Adults may have a less dramatic presentation, often with severe sore throat disproportionate to physical findings and sometimes without fever.
On physical examination, patients may exhibit respiratory distress, inspiratory stridor, and a characteristic muffled “hot potato” voice. Children often adopt a tripod position—sitting upright, leaning forward, and extending the neck—to maximize airway patency. Drooling is common due to difficulty swallowing. Severe cases may present with cyanosis, shock, or altered consciousness. Direct examination of the throat with a tongue depressor in children should be avoided, as it may trigger laryngospasm and complete airway obstruction.
Diagnosis should prioritize airway safety. Laboratory findings may show leukocytosis, and blood or epiglottic cultures may identify the causative organism. Imaging, such as a lateral neck X-ray, may reveal the classic “thumb sign” indicating a swollen epiglottis, but should only be performed when airway management is immediately available. Definitive diagnosis is made by visualization of a swollen, erythematous (“cherry-red”) epiglottis using fiberoptic laryngoscopy in a controlled setting.
The differential diagnosis includes croup, diphtheria, allergic laryngeal edema, foreign-body aspiration, peritonsillar abscess, and retropharyngeal abscess. Croup typically has a more gradual onset and lacks significant drooling, while diphtheria presents with a characteristic pseudomembrane.
Management of epiglottitis is an emergency focused on securing the airway. In children, early intubation is strongly recommended, as observation alone carries a high risk of mortality. If intubation is not possible, an emergency tracheostomy or cricothyrotomy may be required. Adults may sometimes be managed more conservatively, but any signs of respiratory compromise necessitate airway intervention.
Intravenous antibiotic therapy should be initiated promptly, targeting likely pathogens, particularly H. influenzae. Recommended regimens include ceftriaxone, cefotaxime, or ampicillin-sulbactam for approximately 10 days. The use of chloramphenicol is now rare due to toxicity. There is insufficient evidence to support routine use of corticosteroids or epinephrine.
All patients require hospital admission, often to an intensive care unit, for close monitoring. Airway stability is the primary concern during initial management, and intravenous fluids are frequently required. In children, intravenous access should not be attempted before securing the airway to avoid provoking distress.
Patients typically show rapid clinical improvement within 12–48 hours after starting appropriate therapy. Extubation can be considered once the patient is afebrile, clinically stable, and has evidence of reduced airway edema on examination. Adults managed without intubation require close ICU monitoring.
The prognosis largely depends on early airway management. Mortality is low when treated promptly but increases significantly if airway obstruction occurs. Rarely, recurrence may occur.
Complications include complete airway obstruction leading to hypoxia and potential brain injury, bacteremia with metastatic infections such as meningitis or arthritis, and complications related to airway management such as aspiration, pneumothorax, or tracheal injury.
- Published on
Infectious Disease and Microbiology – Diverticulitis
Diverticulitis is an inflammatory condition of a diverticulum, which is a pouch formed by herniation of the mucosal layer through a weak point in the muscular wall of the gastrointestinal tract. While diverticula can occur throughout the GI tract, they are most commonly found in the colon, particularly where the vasa recta penetrate the bowel wall. The presence of diverticula without inflammation is referred to as diverticulosis or diverticular disease, whereas diverticulitis specifically indicates inflammation and possible infection.
The condition is more prevalent in Western populations and increases significantly with age, affecting fewer than 5% of individuals under 40 years old but up to 65–80% of those over 70. It accounts for more than 130,000 hospital admissions annually in the United States. Both males and females are affected equally. In Western countries, diverticulitis typically involves the descending and sigmoid colon, whereas right-sided disease is more common in Asian populations.
Risk factors include a low-fiber diet, which leads to decreased stool bulk and increased intraluminal pressure, obesity, sedentary lifestyle, and immunosuppression (e.g., organ transplant recipients). The underlying mechanism involves increased pressure within the colon at weak points, leading to formation of diverticula. Subsequent pressure and irritation can result in inflammation, microperforations, or infection by polymicrobial flora, particularly anaerobes and gram-negative bacteria. Complicated diverticulitis may involve abscess formation, peritonitis, or fistula development and is classified using Hinchey’s staging system.
Clinically, diverticulitis presents with variable severity. Common symptoms include low-grade fever, abdominal pain that often starts in the epigastric region and localizes to the left lower quadrant, and changes in bowel habits such as constipation or diarrhea. In severe cases, perforation may lead to peritoneal signs like guarding and rebound tenderness. Patients with fistula formation may report pneumaturia, fecaluria, or recurrent urinary tract infections.
On physical examination, tenderness is usually localized to the left lower quadrant, sometimes accompanied by signs of peritoneal irritation. A tender mass may be palpable on rectal examination if inflammation is adjacent to the rectum. Mild rectal bleeding may occur but is rarely significant.
Diagnosis is supported by laboratory findings such as leukocytosis and confirmed primarily through imaging. CT scanning is the most reliable diagnostic modality, with high sensitivity and specificity, demonstrating findings such as bowel wall thickening, pericolic fat inflammation, diverticula, and abscess formation. Ultrasound may be used but is more operator-dependent. Endoscopy is generally avoided during the acute phase due to risk of perforation.
Management includes antibiotic therapy targeting anaerobic and gram-negative organisms. Common regimens include ciprofloxacin plus metronidazole, trimethoprim-sulfamethoxazole plus metronidazole, or amoxicillin-clavulanate for 7–10 days. Mild cases can often be managed outpatient, while severe cases or those unable to tolerate oral intake require hospitalization and intravenous therapy. Surgical intervention may be necessary for complications such as abscesses, perforation, or peritonitis. Percutaneous drainage may be used for larger abscesses, and elective surgery may be considered after recovery to prevent recurrence.
After resolution of the acute episode, patients are advised to adopt a high-fiber diet to reduce recurrence risk. Colonoscopy is recommended to exclude underlying malignancy. Although many patients recover fully, recurrence is common, and a subset will require surgical management.
Prognosis depends on disease severity, with mortality rates increasing in advanced stages of disease. Potential complications include perforation, abscess formation, fistula development, bowel obstruction, sepsis, and rarely pylephlebitis or hepatic abscess.
Diverticulitis is an inflammatory condition of a diverticulum, which is a pouch formed by herniation of the mucosal layer through a weak point in the muscular wall of the gastrointestinal tract. While diverticula can occur throughout the GI tract, they are most commonly found in the colon, particularly where the vasa recta penetrate the bowel wall. The presence of diverticula without inflammation is referred to as diverticulosis or diverticular disease, whereas diverticulitis specifically indicates inflammation and possible infection.
The condition is more prevalent in Western populations and increases significantly with age, affecting fewer than 5% of individuals under 40 years old but up to 65–80% of those over 70. It accounts for more than 130,000 hospital admissions annually in the United States. Both males and females are affected equally. In Western countries, diverticulitis typically involves the descending and sigmoid colon, whereas right-sided disease is more common in Asian populations.
Risk factors include a low-fiber diet, which leads to decreased stool bulk and increased intraluminal pressure, obesity, sedentary lifestyle, and immunosuppression (e.g., organ transplant recipients). The underlying mechanism involves increased pressure within the colon at weak points, leading to formation of diverticula. Subsequent pressure and irritation can result in inflammation, microperforations, or infection by polymicrobial flora, particularly anaerobes and gram-negative bacteria. Complicated diverticulitis may involve abscess formation, peritonitis, or fistula development and is classified using Hinchey’s staging system.
Clinically, diverticulitis presents with variable severity. Common symptoms include low-grade fever, abdominal pain that often starts in the epigastric region and localizes to the left lower quadrant, and changes in bowel habits such as constipation or diarrhea. In severe cases, perforation may lead to peritoneal signs like guarding and rebound tenderness. Patients with fistula formation may report pneumaturia, fecaluria, or recurrent urinary tract infections.
On physical examination, tenderness is usually localized to the left lower quadrant, sometimes accompanied by signs of peritoneal irritation. A tender mass may be palpable on rectal examination if inflammation is adjacent to the rectum. Mild rectal bleeding may occur but is rarely significant.
Diagnosis is supported by laboratory findings such as leukocytosis and confirmed primarily through imaging. CT scanning is the most reliable diagnostic modality, with high sensitivity and specificity, demonstrating findings such as bowel wall thickening, pericolic fat inflammation, diverticula, and abscess formation. Ultrasound may be used but is more operator-dependent. Endoscopy is generally avoided during the acute phase due to risk of perforation.
Management includes antibiotic therapy targeting anaerobic and gram-negative organisms. Common regimens include ciprofloxacin plus metronidazole, trimethoprim-sulfamethoxazole plus metronidazole, or amoxicillin-clavulanate for 7–10 days. Mild cases can often be managed outpatient, while severe cases or those unable to tolerate oral intake require hospitalization and intravenous therapy. Surgical intervention may be necessary for complications such as abscesses, perforation, or peritonitis. Percutaneous drainage may be used for larger abscesses, and elective surgery may be considered after recovery to prevent recurrence.
After resolution of the acute episode, patients are advised to adopt a high-fiber diet to reduce recurrence risk. Colonoscopy is recommended to exclude underlying malignancy. Although many patients recover fully, recurrence is common, and a subset will require surgical management.
Prognosis depends on disease severity, with mortality rates increasing in advanced stages of disease. Potential complications include perforation, abscess formation, fistula development, bowel obstruction, sepsis, and rarely pylephlebitis or hepatic abscess.
- Published on
Infectious Disease and Microbiology – E. coli Infections
Escherichia coli are Gram-negative, rod-shaped bacteria that are part of the normal intestinal flora but can also cause a wide range of infections. They are among the most important pathogens in both community-acquired and hospital-acquired infections.
Epidemiologically, E. coli is the leading cause of nosocomial bacteremia and is responsible for more than 80% of acute uncomplicated urinary tract infections in young women. It is also a major cause of traveler’s diarrhea, typically acquired via the fecal–oral route through contaminated food or water, especially in tropical and subtropical regions. Urinary tract infections often occur due to colonization of the periurethral area followed by ascending infection. Risk factors in women include sexual activity and use of spermicides or diaphragms. In men, risks include lack of circumcision, anal intercourse, and exposure to colonized partners. Immunocompromised individuals, including those with HIV (especially CD4 <200), are also at increased risk.
Additional risk factors include anatomical abnormalities such as urinary obstruction or stones, immunosuppression (e.g., diabetes, malignancy, steroid use), and certain host susceptibility factors such as inability to secrete blood group antigens, which facilitates bacterial adherence. Preventive strategies include careful use of antibiotic prophylaxis in selected travelers and avoiding unnecessary screening for asymptomatic bacteriuria except in specific groups such as pregnant women.
The pathophysiology of E. coli infections is based on its ability to adhere to host cells and produce toxins. Different strains have distinct pathogenic mechanisms. Enterotoxigenic E. coli (ETEC) produces toxins that increase cyclic nucleotide levels, leading to increased chloride secretion and watery diarrhea. Enteropathogenic strains disrupt intestinal mucosa, especially in children. Enteroinvasive strains invade intestinal cells, causing inflammatory diarrhea. Enterohemorrhagic E. coli (EHEC), such as O157:H7, produces Shiga toxin and can cause hemorrhagic colitis and hemolytic–uremic syndrome, often associated with contaminated beef or dairy products. Enteroaggregative strains are linked to persistent diarrhea, particularly in travelers and immunocompromised patients.
Uropathogenic E. coli strains possess specific virulence factors, including pili that allow adherence to uroepithelial cells, leading to infections ranging from cystitis to pyelonephritis and even septicemia. Beyond the urinary and gastrointestinal systems, E. coli can cause intra-abdominal infections such as abscesses, cholecystitis, and cholangitis. It is also associated with serious conditions including meningitis in neonates, as well as endocarditis, pneumonia, osteomyelitis, septic arthritis, and other systemic infections.
Diagnosis is confirmed by isolating E. coli from normally sterile sites such as blood, cerebrospinal fluid, or bile. In diarrheal illness, specialized testing such as PCR or toxin detection may be required to identify specific pathogenic strains. Imaging studies like abdominal CT or ultrasound may help identify complications such as abscesses or hepatobiliary infections. The differential diagnosis depends on the clinical presentation and includes other bacterial causes such as Campylobacter, Salmonella, and Shigella, particularly in cases of bloody diarrhea.
Treatment depends on the type and severity of infection. Localized infections require both antimicrobial therapy and, when necessary, drainage of abscesses or removal of infected material. Traveler’s diarrhea is commonly treated with short courses of fluoroquinolones or trimethoprim–sulfamethoxazole, along with supportive therapy such as hydration and antidiarrheal agents. However, antibiotics are generally avoided in EHEC infections due to the risk of worsening toxin-mediated complications such as hemolytic–uremic syndrome.
Uncomplicated cystitis is treated with short courses of oral antibiotics, while pyelonephritis requires longer treatment and sometimes hospitalization for intravenous therapy. Severe infections such as bacteremia or sepsis require broad-spectrum intravenous antibiotics, including fluoroquinolones, third-generation cephalosporins, or carbapenems. Pregnant patients require specific antibiotic choices such as penicillins, cephalosporins, or nitrofurantoin.
Follow-up is important in patients with persistent bacteremia or recurrent infections, as these may indicate underlying abnormalities such as abscesses, urinary tract obstruction, or foreign bodies. Prognosis is generally good with appropriate treatment, although complications such as dehydration, septic shock, and hemolytic–uremic syndrome can occur. Severe systemic infections may be life-threatening, particularly in vulnerable populations such as those with liver disease, immunosuppression, or impaired immune function.
- Published on
Infectious Disease and Microbiology – Echinococcosis
Echinococcosis, also known as hydatid disease, is a parasitic infection caused by species of the genus Echinococcus. The most important species include Echinococcus granulosus, which causes cystic echinococcosis (CE), Echinococcus multilocularis, which causes alveolar echinococcosis (AE), and Echinococcus vogeli, which causes polycystic echinococcosis. These infections are characterized by the formation of cysts in various organs, most commonly the liver and lungs.
The disease is endemic in many parts of the world. Cystic echinococcosis is prevalent in Central Asia, South America, and North Africa, while alveolar echinococcosis is increasingly reported in Central Europe and is highly endemic in parts of China. Polycystic echinococcosis is rare and primarily found in Latin America. Transmission is closely associated with rural environments and animal husbandry practices. Humans acquire infection through contact with infected definitive hosts, typically dogs in CE and foxes or wild canids in AE, or through ingestion of food or water contaminated with parasite eggs.
Risk factors include close contact with dogs or other canines, exposure to livestock such as sheep, poor hygiene, and residence in endemic rural areas. Inadequate slaughterhouse practices and allowing dogs access to infected animal viscera perpetuate the parasite’s lifecycle. Preventive measures focus on improved hygiene, control of stray dog populations, proper disposal of animal remains, and vaccination of livestock.
After ingestion, parasite eggs hatch in the intestine, and larvae penetrate the intestinal wall to enter the bloodstream. They are carried to target organs, most commonly the liver (about 65%) and lungs (about 20%), where they develop into slowly growing cysts. These cysts may produce daughter cysts and can enlarge over time, causing pressure effects. In alveolar echinococcosis, lesions are typically infiltrative and destructive, resembling malignant tumors such as hepatocellular carcinoma and often confined to the liver.
Clinically, cystic echinococcosis is often asymptomatic and discovered incidentally. Symptoms arise due to mass effect depending on the organ involved. Complications include cyst rupture, which may lead to anaphylactic shock, dissemination of infection, or communication with adjacent structures such as the biliary tract or bronchial tree. Physical examination findings are often minimal, though hepatomegaly or a palpable mass may be present.
Diagnosis relies primarily on imaging and serology. Ultrasound is the initial modality of choice, particularly for hepatic cysts, and may reveal characteristic features such as daughter cysts, multilocular appearance, or specific signs like the “water lily” sign. CT and MRI provide further characterization. Serologic testing, typically using ELISA, supports the diagnosis, although sensitivity varies. Eosinophilia may be present but is not consistent. Cyst puncture is generally contraindicated due to the risk of anaphylaxis and parasite dissemination.
Treatment depends on the type and stage of disease. Surgical removal of cysts is the mainstay of treatment for cystic echinococcosis and is often curative. Albendazole is the primary pharmacologic therapy and is used in inoperable cases, disseminated disease, or as adjunctive therapy before and after surgery. Mebendazole is less effective, while praziquantel may be used as an adjunct in selected cases. A less invasive approach, known as PAIR (puncture, aspiration, injection, reaspiration), is used in selected cases and has shown promising results when combined with antiparasitic therapy.
Alveolar echinococcosis requires more aggressive management, often involving radical surgery combined with long-term albendazole therapy, though outcomes are less favorable compared to cystic disease. Follow-up is mainly performed using imaging to monitor cyst progression or recurrence.
Prognosis is generally excellent for cystic echinococcosis with appropriate treatment, whereas alveolar echinococcosis carries a higher mortality if untreated. Complications include cyst rupture with anaphylaxis, secondary infection, dissemination of the parasite, and in AE, progressive tissue destruction with metastatic-like spread.
Echinococcosis, also known as hydatid disease, is a parasitic infection caused by species of the genus Echinococcus. The most important species include Echinococcus granulosus, which causes cystic echinococcosis (CE), Echinococcus multilocularis, which causes alveolar echinococcosis (AE), and Echinococcus vogeli, which causes polycystic echinococcosis. These infections are characterized by the formation of cysts in various organs, most commonly the liver and lungs.
The disease is endemic in many parts of the world. Cystic echinococcosis is prevalent in Central Asia, South America, and North Africa, while alveolar echinococcosis is increasingly reported in Central Europe and is highly endemic in parts of China. Polycystic echinococcosis is rare and primarily found in Latin America. Transmission is closely associated with rural environments and animal husbandry practices. Humans acquire infection through contact with infected definitive hosts, typically dogs in CE and foxes or wild canids in AE, or through ingestion of food or water contaminated with parasite eggs.
Risk factors include close contact with dogs or other canines, exposure to livestock such as sheep, poor hygiene, and residence in endemic rural areas. Inadequate slaughterhouse practices and allowing dogs access to infected animal viscera perpetuate the parasite’s lifecycle. Preventive measures focus on improved hygiene, control of stray dog populations, proper disposal of animal remains, and vaccination of livestock.
After ingestion, parasite eggs hatch in the intestine, and larvae penetrate the intestinal wall to enter the bloodstream. They are carried to target organs, most commonly the liver (about 65%) and lungs (about 20%), where they develop into slowly growing cysts. These cysts may produce daughter cysts and can enlarge over time, causing pressure effects. In alveolar echinococcosis, lesions are typically infiltrative and destructive, resembling malignant tumors such as hepatocellular carcinoma and often confined to the liver.
Clinically, cystic echinococcosis is often asymptomatic and discovered incidentally. Symptoms arise due to mass effect depending on the organ involved. Complications include cyst rupture, which may lead to anaphylactic shock, dissemination of infection, or communication with adjacent structures such as the biliary tract or bronchial tree. Physical examination findings are often minimal, though hepatomegaly or a palpable mass may be present.
Diagnosis relies primarily on imaging and serology. Ultrasound is the initial modality of choice, particularly for hepatic cysts, and may reveal characteristic features such as daughter cysts, multilocular appearance, or specific signs like the “water lily” sign. CT and MRI provide further characterization. Serologic testing, typically using ELISA, supports the diagnosis, although sensitivity varies. Eosinophilia may be present but is not consistent. Cyst puncture is generally contraindicated due to the risk of anaphylaxis and parasite dissemination.
Treatment depends on the type and stage of disease. Surgical removal of cysts is the mainstay of treatment for cystic echinococcosis and is often curative. Albendazole is the primary pharmacologic therapy and is used in inoperable cases, disseminated disease, or as adjunctive therapy before and after surgery. Mebendazole is less effective, while praziquantel may be used as an adjunct in selected cases. A less invasive approach, known as PAIR (puncture, aspiration, injection, reaspiration), is used in selected cases and has shown promising results when combined with antiparasitic therapy.
Alveolar echinococcosis requires more aggressive management, often involving radical surgery combined with long-term albendazole therapy, though outcomes are less favorable compared to cystic disease. Follow-up is mainly performed using imaging to monitor cyst progression or recurrence.
Prognosis is generally excellent for cystic echinococcosis with appropriate treatment, whereas alveolar echinococcosis carries a higher mortality if untreated. Complications include cyst rupture with anaphylaxis, secondary infection, dissemination of the parasite, and in AE, progressive tissue destruction with metastatic-like spread.
- Published on
Infectious Disease and Microbiology – Ehrlichiosis and Anaplasmosis
Ehrlichiosis and anaplasmosis are systemic infections caused by obligate intracellular bacteria belonging to the family Anaplasmataceae, which includes the genera Ehrlichia, Anaplasma, Neorickettsia, and Wolbachia. These organisms primarily infect humans through tick bites, especially during the summer months when tick activity is highest. They target cells of the reticuloendothelial system, particularly monocytes and granulocytes, leading to a wide range of clinical manifestations. In immunocompetent individuals, the disease is often mild to moderate, presenting with nonspecific symptoms such as fever, malaise, headache, myalgias, nausea, and vomiting. However, in immunocompromised patients, including those with AIDS or on corticosteroid therapy, infections may become severe, with central nervous system involvement, multiple organ dysfunction, and even death.
Epidemiologically, ehrlichiosis and anaplasmosis are primarily reported in the United States but also occur worldwide. Human monocytic ehrlichiosis (HME), caused by Ehrlichia chaffeensis, is transmitted mainly by the tick Amblyomma americanum, particularly in the southeastern and south-central US. Human granulocytic anaplasmosis (HGA), caused by Anaplasma phagocytophilum, is transmitted by Ixodes scapularis, with most cases reported in regions such as Wisconsin, Minnesota, New England, New Jersey, and New York. Cases are also reported in parts of Europe. Subclinical infections are common, and many cases are underdiagnosed. Coinfections with other tick-borne pathogens, such as Babesia microti and Borrelia burgdorferi, may occur due to shared vectors.
Risk factors include exposure to tick-infested environments, outdoor activities in endemic areas, and immunosuppression. Prevention focuses on avoiding tick bites by wearing protective clothing, using insect repellents containing DEET, and performing thorough body checks after potential exposure. Prompt removal of ticks is essential to reduce transmission risk.
The pathophysiology involves bacterial invasion of host immune cells, where the organisms reside within membrane-bound vacuoles. Ehrlichia chaffeensis primarily infects macrophages, while Anaplasma phagocytophilum targets granulocytes. These infections lead to hematologic abnormalities such as leukopenia and thrombocytopenia, as well as systemic inflammation. If untreated, the disease can progress to severe multisystem involvement.
Clinically, symptoms usually develop about 7 days after a tick bite. Patients present with fever, malaise, headache, myalgias, nausea, and sometimes rash, which may be maculopapular or hemorrhagic. Lymphadenopathy and hepatosplenomegaly may occur. Severe cases can progress to septic shock, acute respiratory distress syndrome, and neurological complications such as seizures or coma. Human granulocytic anaplasmosis presents similarly but may lack rash unless there is coinfection with other tick-borne diseases.
Diagnosis is based on clinical suspicion supported by laboratory findings. Common laboratory abnormalities include leukopenia, thrombocytopenia, anemia, and elevated liver enzymes. Serologic testing using indirect immunofluorescence is considered the gold standard but may be negative early in the disease. Polymerase chain reaction (PCR) testing offers higher sensitivity during acute infection but requires specialized laboratories. Blood smear examination has low sensitivity. Imaging such as chest X-ray may show findings consistent with acute respiratory distress syndrome in severe cases.
The differential diagnosis includes other infectious and noninfectious conditions such as endocarditis, septicemia, vasculitis, thrombotic thrombocytopenic purpura, and other tick-borne illnesses including tularemia, babesiosis, Lyme disease, Rocky Mountain spotted fever, and murine typhus.
Treatment should be initiated promptly when the disease is suspected. Doxycycline is the first-line therapy and is effective for both ehrlichiosis and anaplasmosis, typically resulting in clinical improvement within 24–48 hours. Treatment duration is usually 7–14 days. In cases where doxycycline cannot be used, such as pregnancy, rifampin may be considered. Chloramphenicol has been used but is less reliable and may not be effective in all cases.
Follow-up is important to ensure clinical improvement, as lack of response within 48 hours should prompt reconsideration of the diagnosis. Persistent infection has been reported despite treatment, and expert consultation may be necessary in complicated cases.
Complications can be severe, particularly if untreated. These include respiratory failure, neurological involvement, acute renal failure, gastrointestinal hemorrhage, and death. Hospitalization is common, with a significant proportion of patients developing severe disease. Mortality rates are estimated at 2–5%, with higher risk in elderly and immunocompromised individuals.
- Published on
Infectious Disease And Microbiology – Empyema
Empyema is defined as the accumulation of purulent (pus-containing) fluid within the pleural cavity. It most commonly develops as a complication of bacterial pneumonia but may also arise following thoracic surgery, trauma, esophageal perforation, or subdiaphragmatic infections. In children, empyema is usually secondary to pneumonia—most often caused by Streptococcus pneumoniae—and tends to have a better prognosis than in adults, although management principles are similar. Overall, pleural effusions occur in up to 57% of pneumonia cases, but only about 1–2% progress to empyema. The condition affects individuals of all ages, with higher prevalence in the elderly and in children, and occurs more frequently in males.
Several risk factors predispose individuals to empyema, including diabetes mellitus, alcoholism, substance abuse, rheumatoid arthritis, chronic lung disease, poor dental hygiene, malignancy, and prior thoracic surgery. Conditions that increase the risk of aspiration are particularly associated with anaerobic infections. Prevention focuses on appropriate treatment of pneumonia, adherence to surgical infection control practices, and vaccination (especially pneumococcal vaccination).
The development of empyema progresses through three stages. The exudative stage involves inflammation and fluid accumulation in the pleural space. This is followed by the fibrinopurulent stage, characterized by fibrin deposition and pus formation. Finally, the organizing stage occurs, where fibroblasts proliferate and collagen is deposited, potentially leading to pleural thickening and restricted lung expansion. The causative organisms vary depending on whether the infection is community-acquired or hospital-acquired. Community-acquired empyema commonly involves streptococci, staphylococci, anaerobes, and Enterobacteriaceae, while hospital-acquired cases are more often caused by methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, enterococci, and other resistant organisms.
Clinically, patients often present with a history of pneumonia or thoracic procedures, along with symptoms such as fever, chest pain, and shortness of breath. In elderly or immunocompromised patients, symptoms may be subtle, including weight loss or anemia. On physical examination, findings may include dullness to percussion, decreased tactile fremitus, and absent breath sounds over the affected area, although small effusions may not produce obvious signs.
Diagnosis is confirmed through thoracentesis, with the presence of pus in the pleural space being definitive. Laboratory evaluation includes complete blood count and inflammatory markers such as C-reactive protein. Pleural fluid analysis is essential and typically shows low pH (<7.2), high white blood cell count, and positive Gram stain or culture. Imaging plays a key role: chest X-ray identifies pleural effusion, ultrasound helps localize fluid and guide drainage, and CT scan can distinguish empyema from lung abscess (notably showing the “split pleura” sign).
The differential diagnosis includes other causes of pleural effusion, lung abscess, and pneumonia. Management requires prompt initiation of antimicrobial therapy along with drainage of the infected fluid, usually via chest tube. Antibiotic regimens differ based on whether the infection is community- or hospital-acquired and should cover likely pathogens, including anaerobes and resistant organisms where appropriate. Adjunctive treatments include adequate hydration, nutritional support, and, in some cases, intrapleural fibrinolytic therapy to improve drainage.
In cases where drainage is incomplete or complications arise, surgical intervention may be necessary. Options include video-assisted thoracoscopic surgery (VATS), thoracotomy with decortication, or other open surgical procedures. Most patients require hospitalization for intravenous antibiotics and monitoring. Follow-up involves continued antibiotic therapy for 2–4 weeks, monitoring inflammatory markers, and ensuring adequate drainage. Chest tubes are typically removed once drainage decreases and fluid clears.
The prognosis of empyema varies depending on patient factors and timeliness of treatment. While many patients recover with appropriate management, mortality rates range from 7% to 33% within one year and may exceed 50% in patients with significant comorbidities. Complications include pleural thickening, pulmonary fibrosis, pneumothorax, bronchopleural fistula, respiratory failure, septic shock, and, in rare cases, empyema necessitatis.
- Published on
Infectious Disease And Microbiology – Encephalitis
Encephalitis is an inflammation of the brain parenchyma that leads to neurological dysfunction and is most commonly caused by infections. These infections may be viral, bacterial, fungal, or protozoal, with viruses being the most frequent cause. The condition typically arises when pathogens spread to the central nervous system via the bloodstream, although some, such as rabies, travel through peripheral nerves. Clinically, encephalitis often presents with fever, headache, confusion, and altered mental status, and may also involve seizures or focal neurological deficits.
Epidemiologically, encephalitis affects both extremes of age, particularly the very young and the elderly. Viral encephalitis is the most common form, with an annual incidence of approximately 3.5–7.4 cases per 100,000 people, accounting for around 20,000 new cases each year. In the United States, herpes simplex virus (HSV) is the leading identifiable cause, responsible for about 10% of all cases. In neonates, HSV-2 is the most common cause and is typically acquired during delivery. In many cases—up to 75%—no specific causative agent is identified.
Risk factors for encephalitis include age, immune status, seasonal exposure, and environmental or travel-related exposures. Arboviral infections are more common during summer and fall, while HSV infections occur year-round. Exposure to mosquitoes, ticks, animals, or contaminated water sources increases risk. Preventive strategies include avoiding insect bites, implementing vector control measures, and vaccination against preventable viral causes such as measles, mumps, rubella, polio, varicella, and Japanese encephalitis.
The pathophysiology varies depending on the causative organism but generally involves viremia followed by invasion of the central nervous system. This leads to inflammation, neuronal injury, and sometimes necrosis. In HSV encephalitis, the temporal lobes are commonly affected, whereas other viruses may target different brain regions such as the brainstem or gray matter.
Etiologically, encephalitis has a broad range of causes. Viral pathogens include herpesviruses (HSV, CMV, VZV), arboviruses (e.g., West Nile virus, Japanese encephalitis virus), enteroviruses, rabies virus, and HIV. Bacterial causes include Listeria monocytogenes, Mycobacterium tuberculosis, and Mycoplasma. Other causes include rickettsial organisms, spirochetes such as Borrelia burgdorferi, fungi like Cryptococcus neoformans, and protozoa such as Toxoplasma gondii and Naegleria fowleri. Helminths such as Taenia solium may also be implicated.
Diagnosis relies heavily on clinical suspicion, supported by history and examination. Important historical clues include recent travel, insect or animal exposure, and immune status. Physical examination focuses on neurological findings, though skin examination may reveal rashes that help identify specific etiologies. Because encephalitis may overlap clinically with meningitis, distinguishing between the two can be challenging.
Laboratory evaluation includes cerebrospinal fluid (CSF) analysis obtained via lumbar puncture, which typically shows lymphocytic pleocytosis, elevated protein, and normal glucose in viral cases. PCR testing of CSF is essential for identifying viral pathogens such as HSV, CMV, and VZV. Additional tests may include serology, blood cultures, and pathogen-specific assays depending on clinical suspicion. Imaging is critical, with brain MRI being the gold standard; characteristic findings such as temporal lobe involvement suggest HSV encephalitis. CT scanning is useful when MRI is unavailable or to rule out contraindications to lumbar puncture.
The differential diagnosis is broad and includes meningitis, brain abscess, encephalopathy, acute disseminated encephalomyelitis, metabolic disorders, vasculitis, and drug-induced aseptic meningitis. Management requires prompt empiric therapy. Until bacterial meningitis is excluded, patients should receive broad antimicrobial coverage along with antiviral therapy. Intravenous acyclovir is the treatment of choice for suspected HSV encephalitis and should be started immediately. Other antiviral or antimicrobial treatments depend on the identified pathogen, and adjunctive therapies such as antiretroviral treatment may be required in HIV-related cases.
Patients with encephalitis require hospitalization, often with intensive care monitoring. Supportive care includes adequate hydration, especially during acyclovir therapy to prevent renal toxicity. Close monitoring is essential, as recovery may be prolonged and incomplete.
The prognosis of encephalitis varies widely depending on the causative organism and timeliness of treatment. HSV encephalitis, if untreated, carries a mortality rate of up to 70%, but early treatment reduces mortality to 6–19%. However, many survivors experience long-term neurological deficits. Younger patients tend to have better outcomes.
Complications of encephalitis include seizures, permanent neurological impairment, relapse (particularly in HSV infection), and death. Long-term follow-up may involve neuropsychological assessment to evaluate cognitive and functional outcomes.
Encephalitis is an inflammation of the brain parenchyma that leads to neurological dysfunction and is most commonly caused by infections. These infections may be viral, bacterial, fungal, or protozoal, with viruses being the most frequent cause. The condition typically arises when pathogens spread to the central nervous system via the bloodstream, although some, such as rabies, travel through peripheral nerves. Clinically, encephalitis often presents with fever, headache, confusion, and altered mental status, and may also involve seizures or focal neurological deficits.
Epidemiologically, encephalitis affects both extremes of age, particularly the very young and the elderly. Viral encephalitis is the most common form, with an annual incidence of approximately 3.5–7.4 cases per 100,000 people, accounting for around 20,000 new cases each year. In the United States, herpes simplex virus (HSV) is the leading identifiable cause, responsible for about 10% of all cases. In neonates, HSV-2 is the most common cause and is typically acquired during delivery. In many cases—up to 75%—no specific causative agent is identified.
Risk factors for encephalitis include age, immune status, seasonal exposure, and environmental or travel-related exposures. Arboviral infections are more common during summer and fall, while HSV infections occur year-round. Exposure to mosquitoes, ticks, animals, or contaminated water sources increases risk. Preventive strategies include avoiding insect bites, implementing vector control measures, and vaccination against preventable viral causes such as measles, mumps, rubella, polio, varicella, and Japanese encephalitis.
The pathophysiology varies depending on the causative organism but generally involves viremia followed by invasion of the central nervous system. This leads to inflammation, neuronal injury, and sometimes necrosis. In HSV encephalitis, the temporal lobes are commonly affected, whereas other viruses may target different brain regions such as the brainstem or gray matter.
Etiologically, encephalitis has a broad range of causes. Viral pathogens include herpesviruses (HSV, CMV, VZV), arboviruses (e.g., West Nile virus, Japanese encephalitis virus), enteroviruses, rabies virus, and HIV. Bacterial causes include Listeria monocytogenes, Mycobacterium tuberculosis, and Mycoplasma. Other causes include rickettsial organisms, spirochetes such as Borrelia burgdorferi, fungi like Cryptococcus neoformans, and protozoa such as Toxoplasma gondii and Naegleria fowleri. Helminths such as Taenia solium may also be implicated.
Diagnosis relies heavily on clinical suspicion, supported by history and examination. Important historical clues include recent travel, insect or animal exposure, and immune status. Physical examination focuses on neurological findings, though skin examination may reveal rashes that help identify specific etiologies. Because encephalitis may overlap clinically with meningitis, distinguishing between the two can be challenging.
Laboratory evaluation includes cerebrospinal fluid (CSF) analysis obtained via lumbar puncture, which typically shows lymphocytic pleocytosis, elevated protein, and normal glucose in viral cases. PCR testing of CSF is essential for identifying viral pathogens such as HSV, CMV, and VZV. Additional tests may include serology, blood cultures, and pathogen-specific assays depending on clinical suspicion. Imaging is critical, with brain MRI being the gold standard; characteristic findings such as temporal lobe involvement suggest HSV encephalitis. CT scanning is useful when MRI is unavailable or to rule out contraindications to lumbar puncture.
The differential diagnosis is broad and includes meningitis, brain abscess, encephalopathy, acute disseminated encephalomyelitis, metabolic disorders, vasculitis, and drug-induced aseptic meningitis. Management requires prompt empiric therapy. Until bacterial meningitis is excluded, patients should receive broad antimicrobial coverage along with antiviral therapy. Intravenous acyclovir is the treatment of choice for suspected HSV encephalitis and should be started immediately. Other antiviral or antimicrobial treatments depend on the identified pathogen, and adjunctive therapies such as antiretroviral treatment may be required in HIV-related cases.
Patients with encephalitis require hospitalization, often with intensive care monitoring. Supportive care includes adequate hydration, especially during acyclovir therapy to prevent renal toxicity. Close monitoring is essential, as recovery may be prolonged and incomplete.
The prognosis of encephalitis varies widely depending on the causative organism and timeliness of treatment. HSV encephalitis, if untreated, carries a mortality rate of up to 70%, but early treatment reduces mortality to 6–19%. However, many survivors experience long-term neurological deficits. Younger patients tend to have better outcomes.
Complications of encephalitis include seizures, permanent neurological impairment, relapse (particularly in HSV infection), and death. Long-term follow-up may involve neuropsychological assessment to evaluate cognitive and functional outcomes.
- Published on
Infectious Disease And Microbiology – Endocarditis (Native Valves)
Endocarditis is an infection of the endocardial surface of the heart, most commonly involving the heart valves. It is typically caused by bacteria, though fungi and, rarely, organisms such as chlamydiae or rickettsiae may be responsible. In native valve infective endocarditis (NVIE), the mitral valve is most frequently affected, followed by the aortic valve. The tricuspid valve is more commonly involved in individuals who use intravenous drugs, while pulmonic valve involvement is rare. In some cases, multiple valves may be infected simultaneously.
The incidence of NVIE ranges from approximately 1.7 to 6.2 cases per 100,000 person-years, but is significantly higher among intravenous drug users. Risk factors include intravenous drug use, prior history of endocarditis, chronic intravascular access, implanted cardiac devices, congenital heart disease, bicuspid aortic valve, rheumatic heart disease, and degenerative valvular disease. Preventive strategies include antibiotic prophylaxis for high-risk individuals—such as those with prosthetic valves, prior endocarditis, certain congenital heart diseases, or cardiac transplant recipients with valvulopathy—especially before dental procedures involving manipulation of the gingiva or oral mucosa.
The most common causative organisms are Gram-positive bacteria, with Staphylococcus aureus now being the leading cause of NVIE. Other important pathogens include viridans group streptococci, Streptococcus bovis, enterococci, coagulase-negative staphylococci, and the HACEK group of organisms. Fungal infections account for a smaller proportion of cases. Approximately 10% of cases are culture-negative, often due to prior antibiotic use or infection with fastidious organisms such as Bartonella or Coxiella burnetii.
Clinically, NVIE presents with a wide range of symptoms resulting from valvular infection, embolic phenomena, metastatic infection, and immune complex deposition. Fever is present in over 90% of patients, along with nonspecific symptoms such as malaise, fatigue, weight loss, and chills. The modified Duke criteria are widely used for diagnosis and incorporate clinical, microbiological, and echocardiographic findings. Major criteria include positive blood cultures with typical organisms and evidence of endocardial involvement on echocardiography, while minor criteria include fever, predisposing conditions, vascular and immunologic phenomena, and less specific microbiologic evidence.
On physical examination, a new or changing heart murmur is found in the majority of patients. Other findings may include petechiae, splinter hemorrhages, Osler nodes, Janeway lesions, and Roth spots, although these are less common. A thorough examination is necessary to detect complications such as embolic events or metastatic infections.
Diagnosis requires prompt laboratory and imaging evaluation. Blood cultures are critical and should be obtained before starting antibiotics, with at least three sets drawn within the first 24 hours. Most cases can be diagnosed based on positive blood cultures. Laboratory findings often include leukocytosis, elevated inflammatory markers, and abnormalities on urinalysis such as hematuria or proteinuria. In cases of culture-negative endocarditis, serologic testing for atypical organisms may be necessary.
Echocardiography is the imaging modality of choice. Transthoracic echocardiography (TTE) is often used initially, but transesophageal echocardiography (TEE) is more sensitive and is preferred when clinical suspicion is high or when TTE results are inconclusive. Imaging may reveal vegetations, abscesses, or valvular dysfunction. Additional imaging studies may be required to evaluate for embolic complications or abscess formation in other organs.
Treatment involves prolonged intravenous bactericidal antibiotic therapy tailored to the causative organism and its antimicrobial susceptibilities. Empiric therapy is initiated based on clinical suspicion and risk factors. Common regimens include penicillin or ceftriaxone for streptococcal infections, ampicillin with gentamicin for enterococci, and nafcillin or vancomycin for Staphylococcus aureus. Therapy typically lasts several weeks to ensure eradication of infection within vegetations.
Surgical intervention is required in approximately 30–50% of cases and is considered in patients with heart failure, uncontrolled infection, large vegetations with recurrent emboli, or complications such as abscess formation. Management often requires a multidisciplinary approach involving cardiology, infectious diseases, and cardiac surgery teams.
Patients with endocarditis require hospitalization for initiation of treatment and close monitoring. Follow-up includes repeated blood cultures to confirm clearance of infection, monitoring for complications, and echocardiography to assess cardiac function after treatment. Patient education is important, particularly regarding oral hygiene and prevention of future infections.
The prognosis of NVIE depends on multiple factors, including the causative organism, patient comorbidities, and presence of complications. Mortality remains significant, with rates approaching 40% at one year. Poor prognostic factors include heart failure, infection with Staphylococcus aureus, older age, immunosuppression, and extension of infection beyond the valve. Complications include heart failure, stroke, systemic emboli, renal infarction, glomerulonephritis, mycotic aneurysms, and metastatic infections such as splenic abscess or meningitis.
Endocarditis is an infection of the endocardial surface of the heart, most commonly involving the heart valves. It is typically caused by bacteria, though fungi and, rarely, organisms such as chlamydiae or rickettsiae may be responsible. In native valve infective endocarditis (NVIE), the mitral valve is most frequently affected, followed by the aortic valve. The tricuspid valve is more commonly involved in individuals who use intravenous drugs, while pulmonic valve involvement is rare. In some cases, multiple valves may be infected simultaneously.
The incidence of NVIE ranges from approximately 1.7 to 6.2 cases per 100,000 person-years, but is significantly higher among intravenous drug users. Risk factors include intravenous drug use, prior history of endocarditis, chronic intravascular access, implanted cardiac devices, congenital heart disease, bicuspid aortic valve, rheumatic heart disease, and degenerative valvular disease. Preventive strategies include antibiotic prophylaxis for high-risk individuals—such as those with prosthetic valves, prior endocarditis, certain congenital heart diseases, or cardiac transplant recipients with valvulopathy—especially before dental procedures involving manipulation of the gingiva or oral mucosa.
The most common causative organisms are Gram-positive bacteria, with Staphylococcus aureus now being the leading cause of NVIE. Other important pathogens include viridans group streptococci, Streptococcus bovis, enterococci, coagulase-negative staphylococci, and the HACEK group of organisms. Fungal infections account for a smaller proportion of cases. Approximately 10% of cases are culture-negative, often due to prior antibiotic use or infection with fastidious organisms such as Bartonella or Coxiella burnetii.
Clinically, NVIE presents with a wide range of symptoms resulting from valvular infection, embolic phenomena, metastatic infection, and immune complex deposition. Fever is present in over 90% of patients, along with nonspecific symptoms such as malaise, fatigue, weight loss, and chills. The modified Duke criteria are widely used for diagnosis and incorporate clinical, microbiological, and echocardiographic findings. Major criteria include positive blood cultures with typical organisms and evidence of endocardial involvement on echocardiography, while minor criteria include fever, predisposing conditions, vascular and immunologic phenomena, and less specific microbiologic evidence.
On physical examination, a new or changing heart murmur is found in the majority of patients. Other findings may include petechiae, splinter hemorrhages, Osler nodes, Janeway lesions, and Roth spots, although these are less common. A thorough examination is necessary to detect complications such as embolic events or metastatic infections.
Diagnosis requires prompt laboratory and imaging evaluation. Blood cultures are critical and should be obtained before starting antibiotics, with at least three sets drawn within the first 24 hours. Most cases can be diagnosed based on positive blood cultures. Laboratory findings often include leukocytosis, elevated inflammatory markers, and abnormalities on urinalysis such as hematuria or proteinuria. In cases of culture-negative endocarditis, serologic testing for atypical organisms may be necessary.
Echocardiography is the imaging modality of choice. Transthoracic echocardiography (TTE) is often used initially, but transesophageal echocardiography (TEE) is more sensitive and is preferred when clinical suspicion is high or when TTE results are inconclusive. Imaging may reveal vegetations, abscesses, or valvular dysfunction. Additional imaging studies may be required to evaluate for embolic complications or abscess formation in other organs.
Treatment involves prolonged intravenous bactericidal antibiotic therapy tailored to the causative organism and its antimicrobial susceptibilities. Empiric therapy is initiated based on clinical suspicion and risk factors. Common regimens include penicillin or ceftriaxone for streptococcal infections, ampicillin with gentamicin for enterococci, and nafcillin or vancomycin for Staphylococcus aureus. Therapy typically lasts several weeks to ensure eradication of infection within vegetations.
Surgical intervention is required in approximately 30–50% of cases and is considered in patients with heart failure, uncontrolled infection, large vegetations with recurrent emboli, or complications such as abscess formation. Management often requires a multidisciplinary approach involving cardiology, infectious diseases, and cardiac surgery teams.
Patients with endocarditis require hospitalization for initiation of treatment and close monitoring. Follow-up includes repeated blood cultures to confirm clearance of infection, monitoring for complications, and echocardiography to assess cardiac function after treatment. Patient education is important, particularly regarding oral hygiene and prevention of future infections.
The prognosis of NVIE depends on multiple factors, including the causative organism, patient comorbidities, and presence of complications. Mortality remains significant, with rates approaching 40% at one year. Poor prognostic factors include heart failure, infection with Staphylococcus aureus, older age, immunosuppression, and extension of infection beyond the valve. Complications include heart failure, stroke, systemic emboli, renal infarction, glomerulonephritis, mycotic aneurysms, and metastatic infections such as splenic abscess or meningitis.
- Published on
Infectious Disease and Microbiology: Fungal Infections of the Hair, Skin, and Nails (Dermatophytosis / Tinea)
Fungal infections of the hair, skin, and nails—collectively known as dermatophytosis or tinea—are common infectious diseases affecting keratinized tissues. These infections are caused by dermatophyte fungi that invade the superficial layers of the skin, hair, or nails through enzymes such as keratinases. They are classified based on the site of infection, including tinea pedis (feet), tinea corporis (body), tinea cruris (groin), tinea capitis (scalp), and onychomycosis (nails). These infections occur worldwide and are particularly common in hot and humid climates.
Epidemiologically, dermatophytosis affects different populations depending on the type. Tinea capitis is most common in children, while tinea pedis is more frequently seen in young adult males. Onychomycosis is the most common nail disorder in adults. Risk factors include excessive moisture, tight clothing, poor hygiene, diabetes mellitus, obesity, and immunosuppression. Transmission occurs through direct contact with infected individuals, animals, or contaminated objects such as towels, footwear, and communal shower surfaces.
The pathophysiology involves fungal invasion of keratinized structures such as the stratum corneum, hair shafts, and nail beds. The fungi proliferate outward, producing characteristic ring-shaped lesions with central clearing in skin infections. In scalp infections, the hair becomes brittle and breaks, resulting in patches of alopecia. Nail infections lead to thickened, discolored, and brittle nails. The host immune response contributes to inflammation, scaling, and itching, while also attempting to contain the infection.
Clinically, the presentation varies according to the site involved. Tinea pedis typically presents with itching, scaling, and fissuring between the toes. Tinea corporis manifests as circular, erythematous, scaly lesions with raised borders. Tinea cruris causes an itchy rash in the groin area. Tinea capitis presents with scalp scaling, hair loss, and sometimes pustules. Onychomycosis results in thickened, discolored, and brittle nails. Secondary bacterial infection may complicate some cases, especially in tinea pedis.
Diagnosis is usually established by microscopic examination of skin scrapings, hair, or nail samples using potassium hydroxide preparation. Fungal cultures on specialized media can confirm the diagnosis, and Wood’s lamp examination may assist in detecting certain species. Advanced techniques such as polymerase chain reaction may be used in specialized settings.
Treatment depends on the severity and location of the infection. Most superficial infections respond to topical antifungal agents such as Terbinafine, tolnaftate, or undecylenic acid. Oral antifungal therapy, including Griseofulvin or Ketoconazole, is required for more extensive disease, scalp involvement, or nail infections. Onychomycosis typically requires prolonged treatment. Preventive measures such as maintaining hygiene, keeping skin dry, avoiding sharing personal items, and using protective footwear in communal areas are important to prevent recurrence.
The prognosis is generally excellent with appropriate treatment, although recurrence is common if predisposing factors persist. Complications are uncommon but may include secondary bacterial infections, chronic disease, and, in severe scalp infections, permanent hair loss. Early diagnosis and adherence to therapy are essential for successful management.
